These findings demonstrate that CUR may have the potential to reverse the development of depression, and they indicate that the antidepressant mechanisms of CUR are associated with the activation of the PGC-1α/FNDC5/BDNF pathway. The gene discussed is PPARGC1A; the disease is depressive symptom measurement.